Patents by Inventor Damian Handisides

Damian Handisides has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Cancer with Glufosfamide in Patients Not Receiving Insulin Therapy
    Publication number: 20150272973
    Abstract: The co-administration of glufosfamide and a glucose lowering drug other than insulin is efficacious in cancer treatment.
    Type: Application
    Filed: June 27, 2014
    Publication date: October 1, 2015
    Inventors: Damian Handisides, Stewart Kroll, Jian-Xin Duan, Harold E. Selick
  • Treatment of cancer with glufosfamide in patients not receiving insulin therapy
    Patent number: 8765690
    Abstract: The co-administration of glufosfamide and a glucose lowering drug other than insulin is efficacious in cancer treatment.
    Type: Grant
    Filed: April 7, 2008
    Date of Patent: July 1, 2014
    Assignee: Threshold Pharmaceuticals, Inc.
    Inventors: Damian Handisides, Stewart Kroll, Jian-Xin Duan, Harold E. Selick
  • GLUFOSFAMIDE COMBINATION THERAPY
    Publication number: 20100104549
    Abstract: The co-administration of glufosfamide and a glucose lowering drug other than insulin is efficacious in cancer treatment.
    Type: Application
    Filed: April 7, 2008
    Publication date: April 29, 2010
    Applicant: Threshold Pharmaceuticals, Inc.
    Inventors: Damian Handisides, Stewart Kroll, Jian-Xin Duan, Harold E. Selick